Advice
In the absence of a submission from the holder of the marketing authorisation.
gonapeptyl depot is not recommended for use within NHS Scotland for symptomatic endometriosis confirmed by laparoscopy when suppression of the ovarian hormonogenesis is indicated to the extent that surgical therapy is not primarily indicated.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHS Scotland.
Download detailed advice29KB (PDF)
Medicine details
- Medicine name:
- Gonapeptyl depot 3.75mg
- SMC ID:
- 270/06
- Indication:
- Symptomatic endometriosis
- Pharmaceutical company
- Ferring Pharmaceuticals Ltd
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Non submission
- Status
- Not recommended
- Date advice published
- 08 May 2006